|
|
||||||||
Clinical Chemistry, Vol 35, 552-554, Copyright © 1989 by American Association for Clinical Chemistry
A Abe, S Yamashita and A Noma
Department of Laboratory Medicine, Gifu University School of Medicine, Japan.
We have developed a sensitive procedure for determination of serum copper by use of the color reagent 4-(3,5-dibromo-2-pyridylazo)-N-ethyl- N-sulfopropylaniline. After mixing serum sample and reagent, and incubating at 37 degrees C for 5 min, we measure the absorbance of the resulting chelate complex at 580 nm (molar absorptivity, 80,000 L.mol- 1.cm-1). Results of the method varied linearly with copper concentration to at least 5 mg/L; the lower limit of detection was 0.1 mg/L. Within-run CVs were 1.6% and 3.3% for copper concentrations of 1.03 and 0.72 mg/L, respectively (n = 10 each). Between-run CV was 2.8% at 1.22 mg/L (n = 14). Results of the proposed method (y) correlated well with those determined by standard atomic absorption spectrophotometric techniques (x): y = 0.99x - 0.02 mg/L; Syx = 0.08; r = 0.977; n = 56. Iron, zinc, cadmium, cobalt, and lead do not interfere.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. Altamura, R. Squitti, P. Pasqualetti, C. Gaudino, P. Palazzo, F. Tibuzzi, D. Lupoi, M. Cortesi, P. M. Rossini, and F. Vernieri Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke Stroke, April 1, 2009; 40(4): 1282 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, F. Bressi, P. Pasqualetti, C. Bonomini, R. Ghidoni, G. Binetti, E. Cassetta, F. Moffa, M. Ventriglia, F. Vernieri, et al. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease Neurology, January 6, 2009; 72(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, G. Barbati, L. Rossi, M. Ventriglia, G. Dal Forno, S. Cesaretti, F. Moffa, I. Caridi, E. Cassetta, P. Pasqualetti, et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF {beta}-amyloid, and h-tau. Neurology, July 11, 2006; 67(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, P. Pasqualetti, G. Dal Forno, F. Moffa, E. Cassetta, D. Lupoi, F. Vernieri, L. Rossi, M. Baldassini, and P. M. Rossini Excess of serum copper not related to ceruloplasmin in Alzheimer disease Neurology, March 22, 2005; 64(6): 1040 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, E. Cassetta, G. Dal Forno, D. Lupoi, G. Lippolis, F. Pauri, F. Vernieri, A. Cappa, and P. M. Rossini Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment Arch Neurol, May 1, 2004; 61(5): 738 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P. M. Rossini Elevation of serum copper levels in Alzheimer's disease Neurology, October 22, 2002; 59(8): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |